Which of the following is used for treatment of bleeding secondary due to thrombolytic therapy?
Correct Answer: EACA
Description: Ans. C. EACA. (Ref Q. 179 of MH'2006 Paper; Harrison 18th/ch.l16).ThrombolyticsAlteplase (tPA), reteplase (rPA), tenecteplase (TNK-tPA).MechanismDirectly or indirectly aid conversion of plasminogen to plasmin, which cleaves thrombin and fibrin clots. PT, PTT, no change in platelet count.UsesEarly Ml, early ischemic stroke, direct thrombolysis of severe Pulm Embolism.ToxicityBleeding. Contraindicated in patients with active bleeding, history of intracranial bleeding, recent surgery, known bleeding diatheses, or severe hypertension. Treat toxicity with aminocaproic acid (EACA), an inhibitor of fibrinolysis. Fresh frozen plasma and cryoprecipitate can also be used to correct factor deficienciesIn VON WILLEBRAND DISEASE, HEMOPHILIA Antifibrinolytic therapy using either EACA or tranexamic acid is an important therapy, either alone or in an adjunctive capacity, particularly for the prevention or treatment of mucosal bleeding. These agents are particularly useful in prophylaxis for dental procedures, with DDAVP for dental extractions and tonsillectomy, menorrhagia, and prostate procedures. It is contraindicated in the setting of upper urinary tract bleeding, due to the risk of ureteral obstruction. In Inherited Disorders of Platelet Dysfunction, Particularly for mucosal bleeding symptoms, antifibrinolytic therapy (epsilon- aminocaproic acid or tranexamic acid) is used alone or in conjunction with DDAVP or platelet therapy.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now